Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


If a drug company set out to market a miracle pill to insecure young women, it couldn’t do better than the strategy Ortho-McNeil Pharmaceutical has come up with. In multipage advertisements appearing in magazines such as Glamour and Shape, Ortho uses close-up photos of gorgeous models to plug its Ortho Tri-Cyclen birth control pill as a “beauty aid” for “women 15 and over.” One ad calls it “the first pill proven to control blemishes as well as prevent pregnancy.” Oh, that.

A double-blind controlled study commissioned by Ortho found that its drug improved acne in 80 percent of users, and last year Ortho became the first drug company to gain approval from the Food and Drug Administration to market a birth control pill as a hormonal treatment for moderate acne.

Should dermatologists be prescribing birth control pills? Dr. Seth Matarasso, a San Francisco dermatologist, says his young female patients who have seen the Ortho Tri-Cyclen ads routinely ask him about the drug as an acne treatment. However, he is not quick to prescribe it to his patients. “Where do birth control pills fit in? For me, they’re almost a fallback,” Matarasso says, noting that he tries topical regimens, antibacterials, and even the prescription drug Accutane—which has serious side effects—before he’ll prescribe the Pill. “I would not put a 15-year-old on any systemic medication without having a frank discussion with her, her gynecologist, and her parents.”

Despite the fact that the ad campaign targets anxious teens—who may not understand the potential dangers and side effects of birth control pills—the ads have caused little controversy among doctors.

“Some people say facetiously that we should have all women on birth control from age 15 to 50,” says Dr. Elena Gates, chief OB-GYN at the University of California’s Mount Zion Medical Center. Gates calls Ortho Tri-Cyclen a prime example of “a good new drug,” but she acknowledges, “You need to be cautious that advertisers aren’t creating a need where one doesn’t exist.”

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate